Orthofix Medical Inc
ir.orthofix.comOrthofix Medical Inc (NASDAQ: OFIX) is a global medical technology company headquartered in Lewisville, Texas, that designs and sells medical devices and biologics for musculoskeletal conditions. Revenue comes from transactional sales of spinal hardware, bone growth stimulators, biologics, and limb reconstruction products sold through commercial sales channels to hospitals, surgeons, and third-party payors. The company operates two reported segments: Global Spine, which provides implantable spinal devices, biologics, enabling technologies, and bone growth therapies; and a separate limb reconstruction business. Customers include physicians, hospitals, and third-party payors. Bone growth stimulator devices are currently classified as FDA Class III devices, though an FDA panel has recommended reclassification to Class II, which the company's FY2025 10-K filing (accession 000119312526065189, filed 2026-02-24) identifies as a risk that could increase competition and negatively affect sales of those products.
Products & Services
Spinal hardware implants, bone growth stimulators (electromagnetic), biologics, enabling technologies, regenerative solutions, and limb reconstruction devices.
Revenue Model
Transactional product sales of spinal implants, bone growth stimulators, biologics, and limb reconstruction devices through dedicated commercial sales channels to hospitals and physicians.
Customers & Markets
Physicians, hospitals, and third-party payors. End markets include spinal surgery, bone healing, and limb reconstruction.
Geographic Exposure
Global operations with headquarters in Lewisville, Texas. International commercial presence referenced in Global Spine segment strategy as of the FY2025 10-K filing.
Financial Snapshot
Loading...
